Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer-Reference-Cited by-同舟云学术

Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer

Published:2018-01 Issue:1 Volume:286 Page:49-57
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Fukada Ippei,Araki Kazuhiro,Kobayashi Kokoro,Shibayama Tomoko,Takahashi Shunji,Gomi Naoya,Kokubu Yumi,Oikado Katsunori,Horii Rie,Akiyama Futoshi,Iwase Takuji,Ohno Shinji,Hatake Kiyohiko,Sata Naohiro,Ito Yoshinori

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2017161548

Reference31 articles.

1. Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18

2. The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

3. Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

4. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

5. HER2and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The longitudinal changes in multiparametric MRI during neoadjuvant chemotherapy can predict treatment response early in patients with HER2-positive breast cancer;European Journal of Radiology;2024-09

2. Role of oedema and shrinkage patterns for prediction of response to neoadjuvant chemotherapy and survival outcomes in luminal breast cancer;Clinical Radiology;2024-08

3. Radiomic analysis reveals diverse prognostic and molecular insights into the response of breast cancer to neoadjuvant chemotherapy: a multicohort study;Journal of Translational Medicine;2024-07-08

4. Case report: An ultrasound-based approach as an easy tool to evaluate hormone receptor-positive HER-2-negative breast cancer in advanced/metastatic settings: preliminary data of the Plus-ENDO study;Frontiers in Oncology;2024-04-16

5. Neoadjuvant Chemotherapy in Patients with HER2-Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran;Archives of Iranian Medicine;2024-04-01